Project Grant R01DA060319
Award Date 9/1/25
Completion Date 5/31/30
Dollars Obligated $761K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
- This federal Project Grant award of $196,236.00, provided by the National Institute on Drug Abuse (CFDA 93.279 Drug Use and Addiction Research Programs), aims to investigate the mechanisms contributing to preconceptions about those who use cannabis, especially during pregnancy, and the impact on the quality of prenatal care. The key objectives of the 5-year project (July 2025 - June 2030) are to: (1) investigate preconceptions about cannabis use during pregnancy using a mixed-methods approach...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), supports a study on the prevalence and characteristics of cannabidiol (CBD) use during pregnancy. The study aims to: 1) Estimate the prevalence of CBD use overall and by trimester in a clinical sample of 800 pregnant women receiving prenatal care at the University of Colorado; 2) Characterize women who use CBD and/or cannabis during pregnancy in terms...
- This Project Grant award, titled "LONGITUDINAL EFFECTS OF PRENATAL CANNABIS AND TOBACCO CO-EXPOSURE AND POSTNATAL ADVERSITY ON CHILD REGULATION: THE BUFFERING ROLE OF SENSITIVE PARENTING," is funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under CFDA Program 93.279 - Drug Use and Addiction Research Programs. The $149,000 grant will be awarded to the University of Oregon to conduct a secondary analysis of a longitudinal study...
- This Project Grant award of $840,425.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support research examining the impact of pre- and postnatal substance exposure, maternal distress, and related parent-child interpersonal processes on the development of adolescent risk behaviors, including substance use and delinquency. The research will leverage a...
- This $2,267,819 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Abuse and Addiction Research Programs) will fund research by the University of Washington to characterize extracellular vesicle (EV) profiles in healthy pregnancies and those complicated by opioid use disorder. The goal is to identify biomarkers in placental EVs and fetal brain/central nervous system EVs that could predict an infant's risk of developing neonatal opioid withdrawal syndrome (NOWS) and...
- This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400 pregnancies...
- This $1,336,938 Project Grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the impact of chronic prenatal THC exposure on SIV-associated inflammation and impairments in placental and fetal development. The grant was awarded to Tulane University, a private non-profit research university, to conduct this 5-year (September 1, 2025 to May 31, 2030) research project. The goal is to define the...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $621,186 to the University of Wisconsin - Milwaukee to examine the longitudinal impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in youth enrolled in the Adolescent Brain Cognitive Development (ABCD) Study. The project aims to investigate the role of the endocannabinoid system in...
- This $507,000.00 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research at the Icahn School of Medicine at Mount Sinai to investigate the epigenetic mechanisms underlying cannabis use disorder. The project, running from September 1, 2025 to May 31, 2030, aims to leverage a translational animal model of voluntary THC consumption to study sex differences and individual variability in...
- The National Institutes of Health (NIH) awarded Boston Medical Center Corporation a $2,573,346 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The 3-year grant, which commenced on September 1, 2023, will fund a prospective cohort study comparing 100 opioid-exposed pregnancies to 50 non-exposed controls. The study aims to: Compare serial microRNA (miRNA) signatures in opioid-exposed and control pregnancies using maternal plasma and placental tissue samples. The...